The accuracy of transrectal ultrasound prostate volume estimation: Clinical correlations

Sonographic estimates of prostate volume have been applied to the diagnosis and management of prostate cancer. However, we have observed wide variation between transrectal sonographic estimates of prostate volume (TRUS‐V) and the corresponding volumes of unfixed radical prostatectomy specimens (P‐V). Because TRUS‐V may influence the management of men with prostate disease, the relationship between TRUS‐V and P‐V was characterized for 100 consecutive men undergoing a radical retropubic prostatectomy (RRP). For the entire cohort, TRUS‐V (35.9 ± 16.9 mL) underestimated P‐V (45.4 ± 22.9 mL, p < .01). Mean signed percentage error between TRUS‐V and P‐V was − 16 ± 32%. The relationship of TRUS‐V to P‐V was volume dependent (p < .001). For volumes (P‐V) <30 mL, TRUS‐V overestimated P‐V. For volumes (P‐V) >30 mL, TRUS‐V increasingly underestimated P‐V. In summary, transrectal ultrasound estimates of prostate volumes differ significantly from the volume of unfixed RRP specimens. The direction and magnitude of TRUS‐V error is volume dependent. Applied clinically, treatment paradigms employing prostate‐volume‐dependent management algorithms derived from nonuniform methods of volume estimation may not accurately reflect volume nomograms derived from uniform methods of measurement, and thus alter patient management. © 1996 John Wiley & Sons, Inc.

[1]  W. Cooner,et al.  Clinical application of transrectal ultrasonography and prostate specific antigen in the search for prostate cancer. , 1988, Investigative radiology.

[2]  W. Catalona,et al.  Nerve-sparing radical prostatectomy: evaluation of results after 250 patients. , 1990, The Journal of urology.

[3]  A. Pantuck,et al.  Prostate specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer. , 1992, The Journal of urology.

[4]  J. Fracchia,et al.  PSA‐detected prostate cancer: Contrasts with palpable disease , 1995, Journal of surgical oncology.

[5]  M. Terris,et al.  Determination of prostate volume by transrectal ultrasound. , 1991, The Journal of urology.

[6]  R. Gale,et al.  Paraplegia following intrathecal cytosine arabinoside , 1979, Cancer.

[7]  T. Stamey,et al.  Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients. , 1989, The Journal of urology.

[8]  T. Egglin,et al.  Determination of prostate volume with transrectal US for cancer screening. Part II. Accuracy of in vitro and in vivo techniques. , 1991, Radiology.

[9]  W. Ellis,et al.  The inability of prostate specific antigen index to enhance the predictive the value of prostate specific antigen in the diagnosis of prostatic carcinoma. , 1993, The Journal of urology.

[10]  D. Chan,et al.  The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. , 1993, The Journal of urology.

[11]  B. Kelly,et al.  Determination of prostate gland volume by transrectal ultrasound: correlation with radical prostatectomy specimens. , 1991, Scandinavian journal of urology and nephrology. Supplementum.